Name | LAVENDUSTIN C |
Synonyms | HDBA COMPOUND 5 LAVENDUSTIN C 5-(2,5-DIHYDROXYBENZYLAMINO)SALICYLIC ACID 5-(N-2,5-DIHYDROXYBENZYL)AMINOSALICYLIC ACID 5-(N-2',5'-DIHYDROXYBENZYL)AMINOSALICYLIC ACID 5-(2,5-DIHYDROXYBENZYLAMINO)-2-HYDROXYBENZOIC ACID 2-HYDROXY-5-(2,5-DIHYDROXYBENZYLAMINO)BENZOIC ACID [2-HYDROXY-5-[N-(2',5'-DIHYDROXYBENZYL)AMINO]BENZOIC ACID |
CAS | 125697-93-0 |
Molecular Formula | C14H13NO5 |
Molar Mass | 275.26 |
Density | 1.551±0.06 g/cm3(Predicted) |
Melting Point | 193-195°C dec. |
Boling Point | 597.5±50.0 °C(Predicted) |
Solubility | DMSO: soluble |
Appearance | solid |
Color | Light Beige to Brown |
pKa | 2.32±0.10(Predicted) |
Storage Condition | −20°C |
Stability | Hygroscopic |
In vitro study | Lavendustin C (Compound 5) shows potent inhibitory activity, and it may be the core structure responsible for inhibition of tyrosine kinase. Lavendustin C (10-150 µM) inhibits tyrosine kinase-associated neutrophil degranulation and superoxide generation. |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. |
WGK Germany | 3 |
FLUKA BRAND F CODES | 3-10 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.633 ml | 18.165 ml | 36.33 ml |
5 mM | 0.727 ml | 3.633 ml | 7.266 ml |
10 mM | 0.363 ml | 1.816 ml | 3.633 ml |
5 mM | 0.073 ml | 0.363 ml | 0.727 ml |
biological activity | Lavendustin C is a potent inhibitor of Ca2 calmodulin-dependent kinase II (CaMK II), the IC50 was 0.2 μm. Lavendustin C inhibited EGFR-associated tyrosine kinase (IC50=0.012 µm) and pp60c-src() kinase (IC50=0.5 µm). |